In this episode, we dive deep into the world of healthtech with Jim St. Clair, the CEO of MyLigo, a startup revolutionizing patient-centric data solutions. With over 25 years of experience across public and private sectors, Jim shares insights on secure identity verification, AI-driven data exchange in healthcare, and the critical importance of protecting patient identities in an era of increasing cybersecurity threats.

In this episode of the Life Science Success Podcast, I am joined by Jimmy Bechtel, the Vice President of Site Engagement at the Society for Clinical Research Sites, or SCRS. With a diverse background spanning data specialization, patient recruitment, and operations management, Jimmy brings a unique perspective to the clinical research industry.

In this episode of Life Science Success, my guest is John McDonough, the Executive Chairman and CEO of Sunbird Bio. John is a seasoned life sciences executive with over 30 years of experience, known for his impressive track record of raising capital and creating substantial market value. He currently leads Sunbird Bio, a company at the forefront of developing innovative blood-based diagnostic tests for neurological disorders, particularly Alzheimer's disease. John's expertise extends beyond Sunbird Bio, as he also serves as chairman at Cytrellis Biosystems and BioPorto Diagnostics, and is the founder and president of the Crush Colon Cancer Foundation. With a history of successful IPOs, acquisitions, and mergers, John brings a wealth of knowledge and experience to our conversation about the future of neurological diagnostics and the life sciences industry.

Join us on the Life Science Success podcast as we dive into the world of clinical trial innovation with Richie McCann, Head of Global Sales for Site Payments at Greenphire. Discover how this pioneering company is transforming financial management and patient support in global clinical trials.

In this episode, we explore:

• Greenphire’s mission and impact on the clinical trial industry

• Innovative solutions for streamlining trial processes

• Balancing technology with participant experience

• The future of financial management in clinical research.

Don’t miss this insightful conversation on the cutting edge of life sciences.

In this episode of Life Science Success, my guest is John Houston, Ph.D., the Chairperson, Chief Executive Officer, and President of Arvinas. With over three decades of experience in drug discovery and development, Dr. Houston brings valuable insights into pioneering protein degradation therapeutics and the challenges of leading a cutting-edge biotech company.

In this episode of the Life Science Success Podcast, we dive deep into the world of health communication with Michelle Bridenbaker, COO of Unbiased Science at Vital Statistics Consulting. Michelle shares her journey from nursing to leadership in health communications, offering insights into the challenges of conveying accurate scientific information in today's media-saturated landscape. She discusses innovative strategies for pharmaceutical companies to effectively reach healthcare professionals and combat misinformation. Michelle also explores the role of digital transformation in health communication and provides a glimpse into the future of scientific engagement. With her unique perspective on balancing regulatory compliance and dynamic audience engagement, this episode offers valuable insights for anyone interested in the intersection of healthcare, communication, and technology.

Broderick Jones is a seasoned executive with 25 years of experience in Healthcare, Life Sciences, and Financial Services, known for driving growth and operational excellence across key business functions. Currently serving as a senior leader at Verista, he brings his expertise in compliance and validation services to the pharmaceutical, medical device, and biotechnology industries.

In this episode, we dive deep into the world of pharma data science with Dr. Ben Sidders, Chief Science Officer at Biorelate. With two decades of experience in drug discovery, including roles at AstraZeneca and Pfizer, Dr. Sidders shares his journey, insights, and the cutting-edge advancements Biorelate is making in computational oncology and immuno-oncology.

Learn how bioinformatics is reshaping drug discovery and the biggest challenges and opportunities facing the industry today. Plus, Dr. Sidders reveals the greatest leadership advice he's received and what truly inspires, concerns, and excites him in this rapidly evolving field.